|
|
|
|
NOTICES |
|
|
|
The Exchange has observed significant price/volume movement in following scrip/s in the recent past. The Exchange in order to ensure that trading member/investors have latest relevant information had written to the following companies. Reply received from them is attached herewith.
1. Shanti Educational Initiatives Ltd (Security Code: 539921)
2. Parenteral Drugs India Ltd (Security Code: 524689)
3. Trejhara Solutions Ltd (Security Code: 542233)
Further, reply from the following companies are awaited:
4. KSL & Industries Ltd (Security Code: 530149)
5. Samrat Pharmachem Ltd (Security Code: 530125)
For & On behalf of BSE Ltd
Yogendra Daxini
|
Jeevan Noronha
|
Assistant General Manager
|
Senior Manager
|
Surveillance
|
Surveillance
|
January 21st, 2019
|
|